01644oam 2200481 450 991070695480332120210316154901.0(CKB)5470000002459929(OCoLC)852783298(EXLCZ)99547000000245992920130713d2000 ua 0engurbn||||a||||txtrdacontentcrdamediacrrdacarrierCounterfeit bulk drugs hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, June 8 and October 3, 2000Washington :U.S. Government Printing Office,2000.1 online resource (iii, 423 pages) illustrations"Serial no. 106-164."Counterfeit bulk drugs DrugsInspectionUnited StatesDrugsStandardsUnited StatesDrug adulterationGovernment policyUnited StatesPharmaceutical industryUnited StatesQuality controlProduct counterfeitingUnited StatesDrugsInspectionDrugsStandardsDrug adulterationGovernment policyPharmaceutical industryQuality control.Product counterfeitingOCLCEOCLCEOCLCOOCLCQOCLCFOCLCOOCLCQGPOBOOK9910706954803321Counterfeit bulk drugs3436007UNINA